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Abstract 
Long-term exposure ambient particulate matter (PM2.5) may be associated with 
atherosclerosis, increasing the risk of adverse cardiovascular outcomes. Few studies have 
previously examined this relationship, with most research focusing on two different cohorts: the 
Multi-Ethnic Study and Atherosclerosis (MESA) and the Heinz-Nixdorf Recall Study (HNRS). 
While several methods are used to assess the risk of cardiovascular outcomes, this study focuses 
on coronary artery calcification (CAC) as an indicator of atherosclerosis and, therefore, poor 
cardiovascular health. This study aimed to find associations between ambient PM2.5 
concentrations, inflammatory and cardiovascular-specific biomarkers, and CAC. Utilizing data 
from the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) cohort in Allegheny 
County, PA, CAC scores were collected from 724 participants in cohort from 2003-2008 (aged 
45-75 years). A general inflammatory marker, Interleukin-6, the cardiovascular-specific 
augmentation index normalized to 75 beats per minute (AI75), and the Framingham Index 
(FRHI) were also collected. PM2.5 exposure concentrations were determined via active sampling 
and Land Use Regression (LUR). Each participant’s exposure was designated as the PM2.5 
concentration from the prior year within 300 meters of their address.  
All examinations considered potential confounding from age, sex, and race. Statistically 
significant (p < 0.05) associations were found for PM2.5 and IL-6 (0.092), as well as between 
AI75 and CAC (-0.009). Pairwise correlations between PM2.5 and IL-6 (0.05) as well AI75 and  
iv 
FRHI (0.16) were also significant. Comparison of the 90th and 10th percentiles of PM2.5 exposure 
showed a 74.55 HU difference in Agatston score for individuals with presence of CAC. No 
significant association was found between these exposure percentiles and the whether an 
individual developed CAC.  
To date, this is one of the few studies to examine PM2.5 exposure associations to 
atherosclerotic risk using CAC as opposed to CIMT outside of MESA and HNRS. While the 
analysis found suggestive evidence of a direct link between CAC and ambient PM2.5, the results 
were not statistically significant. Pairwise correlations between components of the hypothesized 
pathway were statistically significant, albeit weak. Understanding the association between PM2.5 
and CAC can impact primary and secondary public health prevention efforts for cardiovascular 
disease.   
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I. Introduction 
Air quality has been a major area of concern in environmental health since well before 
the introduction of the Air Pollution Control Act in 1955 [1]. Subsequent legislation, and 
creation of the Clean Air Act of 1970, created the standards by which regions seek attainment on 
several different measures of air quality. Amendments to the Clean Air Act in 1977 and 1990 
provided additional research support to assess the public health effects of various stationary and 
mobile pollution sources [1]. More recently, concern about the effects of ambient air pollution on 
health endpoints such as atherosclerosis, asthma, chronic obstructive pulmonary disease 
(COPD), mortality, stroke, myocardial infarction (MI), and diabetes have grown, as evidenced 
by diverse research within this arena in the past 10 years [2,3].  
 One emerging area of study pertains to the cardiovascular effects of ambient air pollution. 
In a 2010 published statement, the American Heart Association linked poor air quality to 
increased cardiovascular morbidity and mortality rates when compared to areas of higher air 
quality [2]. A key index of air quality is particulate matter (PM), which is one of the six criteria 
pollutants regulated by the US Environmental Protection Agency (EPA) National Ambient Air 
Quality Standards [1]. This paper focuses on the cardiovascular effects of particulate matter that 
is less than 2.5 microns in diameter, also known as fine particulate matter or PM2.5. Effects of 
high PM2.5 exposure include an increased risk of mortality in people with heart or lung disease, 
an increased incidence of asthma, decreased lung function, and a wide-range of respiratory 
effects [4]. Various cardiovascular effects due to PM2.5 exposure include heart rate variability, 
stroke, ischemia, and myocardial infarctions (MI) [5]. As such, cardiovascular morbidity and 
mortality rates have been shown to be elevated with acute increases in ambient PM2.5 [6]. Many 
previous studies have focused on short-term effects of ambient air pollution; however, long-term 
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exposure to ambient fine particulate matter may also lead to increased risk of the adverse health 
effects [6-10, 13].   
 Chronic exposures to ambient air pollution may be associated with atherosclerosis, or the 
thickening of artery walls due to high accumulation of white blood cells, and this health effect is 
also indicative of high risk for acute events such as stroke or MI [12]. Atherosclerosis is 
considered one of the prominent cardiovascular pathologies and can lead to permanent structural 
and functional changes of the arteries [5]. While an individual’s degree of atherosclerosis 
increases over time, other factors can influence the rate of progression [5, 7-9, 11-13]. Potential 
environmental contributors of atherosclerosis have been examined in various cohort studies, 
including the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall 
Study (HNRS) [7-9, 11-13]. Animal studies have also provided ample evidence into the 
toxicological effects and biological plausibility of increasing PM2.5 exposure on atherosclerosis 
progression [5, 13]. Investigations into the long-term effects of ambient PM2.5 exposure on 
atherosclerosis are needed to fully understand the risks associated with specific air quality levels. 
According to Kunzli et al. (2011), preventing the development of atherosclerosis holds larger 
public health significance than focusing on incidences that trigger acute events such as stroke or 
MI as primary prevention efforts have an arguably larger impact than secondary [5].  
 The pathogenesis of atherosclerosis starts at birth and progresses over an individual’s 
lifetime, presumably with additional factors influencing the rate of development. Additionally, 
the degree of atherosclerosis in any individual would reflect a combination of all factors 
influencing an increase in progression. These factors would include genetic predisposition, 
internal (i.e. Body Mass Index), and external influences (i.e. environmental exposures) [5, 10-12, 
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14]. While several noninvasive, subclinical measures have been established to measure the 
degree of atherosclerosis, reliability issues hinder their employment.  
 Kunzli et al. aimed to aggregate current findings and outlined five key criteria for 
surrogate, subclinical markers for atherosclerosis (2011). First, the marker should be continuous, 
indicating a consistent trend with progression of the disease. Repeated measures of the 
subclinical marker would then indicate progression of atherosclerosis. Second, the desired 
marker should be indicative of a long-term load, not just recent exposures. By this measure, 
markers geared solely towards short-term exposures would not adequately capture the chronic 
nature of the exposure. Third, the marker must have high specificity to the cardiovascular 
system, not simply indicative of general inflammation. Fourth, an ideal measure should have a 
causal relationship with the progression of atherosclerosis. Fifth and finally, the marker should 
be affordable, noninvasive, accurate, and reliable [5]. Biomarkers fitting all criteria have been 
utilized in previous clinical assessment studies and primarily focus on two main indicators of 
atherosclerosis [7-9, 11-13]. 
 Carotid intima-media thickness (CIMT), broadly, is the measurement of the tunica intima 
and tunica media within the carotid artery [5]. In theory, these inner layers of the carotid artery 
would increase in thickness with the progression of atherosclerosis. In keeping with the 
guidelines established by Kunzli et al. (2011), the CIMT marker is non-invasive and measured 
via a real-time B-mode ultrasound. CIMT also examines a specific anatomical region across all 
measurements and can be used as a marker for long-term exposure, as increased thickness is not 
very sensitive to acute changes that may occur in day-to-day variation in ambient air pollution 
concentrations. A drawback to the CIMT marker is the possibility of variability in measurement 
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interpretation and quantification. At later stages of atherosclerosis, plaque may cause clinicians 
to overestimate and skew interpretation of CIMT. Therefore, detailed descriptions of individual 
measurements must be considered when comparing across multiple studies [5]. With clear 
explanations of CIMT measurement techniques and standardization of protocols, the negative 
aspects of this measure are nullified and, therefore, can be relied upon for subclinical analysis of 
atherosclerosis.  
 The second main marker utilized as an indicator of atherosclerosis is the amount of 
coronary artery calcification (CAC), measured via the quantity of calcified plaque found in the 
coronary artery. The most common quantification of this measure is the Agatston score, 
measured in Hounsfield Units, and calculated by electron-beam multidetector computed 
tomography [5, 15]. Use of CAC to predict atherosclerosis is not as common as utilization of 
CIMT, but multiple studies have concluded that CAC is a better predictor of cardiovascular 
events compared to CIMT [5, 15]. Although CAC may be more reliable, this marker is largely 
undetectable in individuals under the age of 50 or is very low [5]. For cohorts with a larger 
proportion of young participants under age 50, relying solely on this marker may result in many 
data values of zero, or a positive skew. Use of CAC as an indicator of atherosclerosis does fit the 
other four Kunzli criteria for effective atherosclerosis markers, however. 
 This paper aims to examine the relationship between outdoor PM2.5 exposure and 
subclinical measures of atherosclerosis. A comprehensive review of literature regarding this link 
will be conducted, focusing on studies examining associations between CAC measures with 
ambient PM2.5 concentrations. Following the review, a study of PM2.5 exposures relating to CAC 
measures within the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) cohort 
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will be conducted. Findings from the Heart SCORE cohort will subsequently be compared to 
existing conclusions from previous studies. 
II: Literature Review 
The literature review regarding the link between ambient air pollution and atherosclerosis 
included all articles from a query on PubMed (National Center for Biotechnology Information, 
operated by the National Library of Medicine) and PittCat+ (The University of Pittsburgh 
University Library system). Searches were not limited by date and included articles published 
through January 2015. Searches were conducted using the following terms: “CAC”, “coronary 
artery calcification”, “coronary calcification”, “coronary calcium”, and “augmentation index” in 
all combinations with “particulate matter”, “fine particulates”, or “PM2.5.”   
 The literature search returned five original research articles pertaining to CAC and PM2.5 
within the context of cohort studies on human populations. Animal studies focusing on the 
pathogenicity of coronary calcification were excluded. Of the five relevant studies, population 
data came from two cohorts: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz 
Nixdorf Recall Study (HNRS). Both studies have been approved by appropriate institutional 
ethics boards prior to investigation, and participants gave informed consent [13, 16]. Although 
all five articles included measurements of coronary calcification, only two studies, one from each 
cohort, focused on CAC as an endpoint. Additionally, a review article summarizing several 
measures of atherosclerosis in relation to air pollution was written by Kunzli et al. in 2011, but 
this article did not go into detail about any associations between subclinical measures and PM2.5. 
These following sections will review each cohort and the relevant studies separately, and then 
compare methodologies and results.  
5 
 
A. The Multi-Ethnic Study of Atherosclerosis (MESA) 
 
 MESA is a longitudinal cohort of men and women from 45-84 years of age with initial 
recruitment from 2000-2002 [7, 11]. Participants were initially free of cardiovascular disease at 
the beginning of the study and have been followed over time with current assessment as recent as 
2014. Individuals were recruited from six centers across the United States: Baltimore, Maryland 
(via Johns Hopkins University); Chicago, Illinois (via Northwestern University); Forsyth 
County, North Carolina (via Wake Forest University); Los Angeles, California (via University of 
California-Los Angeles); New York, New York (via Columbia University); and St. Paul 
Minnesota (via the University of Minnesota) [16]. At baseline, 6,814 individuals were included, 
providing residential addresses for exposure assessment and screening for CAC measurements 
[11]. After exclusions, the number of participants in each study center was statistically similar to 
the others. The cohort is 47.4% male and 52.6% female, and the racial distribution of the final 
study size (n=5,172) is: 30% Black, 6.9% Chinese, 20.3% Hispanic, and 42.8% White [11]. 
While some studies of this cohort considered age as a continuous measure, others utilized 10-
year groups (e.g. 44-55 years old) [7-9, 11, 13]. Additionally, some researchers chose to focus on 
certain timeframes to study the cohort, as the original baseline data was collected from 2000-
2002 [16]. The MESA cohort also collects data on smoking status, cholesterol, medication use, 
and hypertension, all of which may influence results [9]. 
1. MESA Methods and Study Design 
 Three of the four studies examined the relationship of CAC with PM2.5 within the MESA 
cohort. Diez Roux et al. (2007) investigated 20-year exposure windows of particulate matter 
(PM10 and PM2.5) related to multiple measures of subclinical atherosclerosis, including CAC. 
This study examined the full effect size of the MESA cohort (n=5,172) and included exposure 
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estimates based on residential addresses. The PM2.5 concentrations used for exposure assignment 
were accessed from the US EPA’s Aerometric Information Retrieval Service database. The 
researchers used spatio-temporal modeling to predict residential exposures for all participants 
based off of monthly PM2.5 averages from the database. Participants residing beyond 10km from 
an air monitor were excluded from analysis, and 20-year exposure estimates were compared with 
ambient PM2.5 concentrations from 2001 (the mid-point of the CAC scoring). The 2001 exposure 
estimates were then used to investigate possible associations with the CAC values collected 
during the baseline examination. The 20-year exposure estimates were not used. CAC values 
were derived from the MESA testing centers, collected using the same methods, and quantified 
using the Agatston score [11]. 
 The next study to utilize the MESA cohort is a prospective study conducted by Kaufman 
et al. published in 2012. This study examined the progression of subclinical atherosclerosis and 
exposure to ambient PM2.5, with the goal of establishing a relationship between ambient PM and 
development of cardiovascular disease. This study utilized the same baseline cohort data as Diez 
Roux et al. 2011, including the CAC levels initially collected from baseline [7, 11]. The 
Kaufman study, however, examined different exposure windows using follow-up examinations 
of the original baseline participants. In addition to the baseline MESA participants, researchers 
also recruited from the MESA Family study, and additional subjects were enrolled for the direct 
purpose of the Kaufman study. In total, the investigation included 6,226 participants from across 
the six MESA study centers – while also adding two more study areas in California and one 
additional in New York State. Follow-up CAC examinations of baseline MESA participants will 
be conducted for 10 years after the initial testing. All other recruits (MESA Family and new 
recruits) were examined from 2005-2007 [7]. PM2.5 data used for exposure assignment will be 
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collected via several methods, mainly relying on outdoor monitoring from integrated samples, 
deterministic models, and geospatial data [17]. Personal exposures for each participant were then 
determined by weighting the external air monitoring measurements with estimated contributions 
from indoor residential pollutant monitoring and reported time-location information [7].   
 Sun et al. (2013) conducted a cross-sectional study investigating exposures of long-term 
PM2.5 (and components) to CAC and CIMT, again in the MESA cohort. Identical to the Diez 
Roux study, researchers used baseline examination data from the original recruitment of MESA 
participants from 2000-2002. Residential addresses were manually cleaned and geocoded after 
participant consent (n= 6,256). Initial exposure assessments were performed in a similar manner 
to the Kaufman study, using air monitoring data from the MESA Air study fixed air monitors [9]. 
The Sun group, however, estimated residential exposure using three different methods: 1) annual 
average concentration of two-week PM2.5 measurements at the monitor nearest to each address, 
2) inverse distance weighting of all annual average PM2.5 monitor concentrations in each area, 
and 3) city-wide averaging of PM2.5 concentrations based on all monitors within the specified 
area [9]. Additionally, the researchers considered the proximity to roadways for monitors due to 
the potential influence from mobile sources. To compensate for this potential confounder, 
monitors within 100 meters of a major road or 50 meters of a secondary road were assigned the 
average value from the area’s MESA Air roadside monitor [9]. 
 Kim et al. in 2014 used a cross-sectional design similar to the Diez Roux and Sun studies 
[8, 9, 11]. Baseline data from the original MESA participant examination were used for clinical 
outcome measures. Residential addresses were geocoded, and the resulting sample size was 
5,488 after the exclusion of participants residing more than 10km away from a sampling monitor. 
The spatio-temporal model of PM2.5 utilized two-week averages from data sampled outdoors 
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MESA Air. The resulting exposure estimates consisted of a spatially-varying long-term mean, 
with a single temporal tendency. The researchers also developed a national spatial model via 
kriging from all monitors across the study domain. Additional details of the procedure are 
described in other papers [8]. 
 All but one of the studies utilized a cross-sectional study design. Only the Kaufman study 
examines the related exposure and outcome measure in a longitudinal fashion, though this claim 
is limited by studies found as of February 2015. Of the studies using data from the MESA 
cohort, each used different methods to determine exposure estimates. Initially, Diez Roux used 
data from the US EPA’s Aerometric Information Retrieval Service database and utilized spatio-
temporal modeling to predict residential exposures. Exposure assessments were then improved 
by Kaufman et al. (2012) by not only relying on outdoor monitoring via integrated samples, but 
also incorporating deterministic models, personal exposures for each participant, contributions 
from indoor pollutant monitoring, and reported time-location information [7]. Sun et al. (2013) 
utilized the same outdoor sampling monitors as Kaufman (MESA Air), but examined exposure 
using three different methods: 1) annual average PM2.5 from the nearest monitor, 2) inverse 
distance weighting, and 3) city-wide averaging [9]. This study also introduced traffic factors 
such as density as a possible influence on the outcome measure. The final, related MESA study 
by Kim et al. (2014) used the same MESA Air monitors as the previous studies, but excluded 
participants living more than 10km away from the nearest monitor as pollutant concentration 
estimates are not as accurate at these distances. Spatio-temporal modeling via universal kriging 
was then conducted to create exposure estimates for the included participants [8]. 
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2. MESA Statistical Analysis and Results 
 Each of the four studies comparing CAC and PM2.5 exposure considered unique methods 
to determine possible associations. Diez Roux et al. identified potential confounders as age, sex, 
race/ethnicity, and associated cardiovascular risk factors (e.g. hypertension, cholesterol levels, 
and smoking status) [11]. To investigate the relationship between the exposure to PM2.5 and 
presence of CAC, investigators used binomial regression after adjustment for the covariates. 
Linear regression was used to compare participants with non-zero CAC scores, which were log-
transformed to normalize the distribution. The investigators also compared the 10th percentile of 
exposure to the 90th percentile to determine the odds ratio of the difference. 
 Diez Roux et al. found that 50% of their study population tested positive for detectable 
CAC, with the mean non-zero Agatston score of 90.3 units [Interquartile Range (IQR) = 285.64 
units]. Of the MESA cohort, 43% remained at the same address for the entirety of the 20-year 
exposure window, and 69% remained within 10km of an outdoor monitor for the study period. 
Imputed particulate matter results from the predictive model showed a 0.93 correlation with 
observed concentrations. Mean 20-year exposures for each participant were used in the analysis 
and also were correlated to the 2001 estimates (0.64, Pearson). From this correlation, researchers 
compared the 2001 estimates to the baseline CAC measures and compared the 10th decile to the 
90th decile of exposure and comparted via relative difference ratios. Diez Roux et al. found that 
PM2.5 exposures were weakly associated with the presence of CAC but were not significant, with 
a ratio of 1.00-1.06 depending on exclusions. The relative difference ratio was also negatively 
associated with CAC for individuals with any calcification, but these results were not significant 
as the confidence intervals included the null value [11]. 
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 Kaufman et al. 2012 also considered the effect modifiers of age, race/ethnicity, gender, 
obesity, diabetes, hypertension, and medication status. Results of this analysis were not available 
as of February 2015. Analysis was conducted separately in a cross-sectional function, as well as 
a longitudinal examination. CAC measurements were compared to the individually-determined 
exposures for each participant. While the Agatston score was utilized for the cross-sectional 
analysis, the longitudinal study required a different quantification of coronary artery calcification 
to show progression of the condition. Investigators noted the same 50% prevalence of CAC in 
the baseline MESA participants, and hypothesized a rate change of +0.074 Agatston units per 
year [7]. Though this study is prospective, the fundamental methodology for exposure 
assessment and outcome estimation should be considered for this review. 
 The next study utilizing the MESA cohort was a cross-sectional design by Sun et al. who 
used linear regression, controlling for several different variables, to estimate associations 
between subclinical measures and PM2.5 exposures. Several models controlling for separate 
confounding factors were considered by this study, however Model 1, controlling for age, sex, 
and race/ethnicity is the most comparable to other studies. This study also considered Agatston 
scores greater than zero (49% of cohort), and overall presence of CAC independently. Based on 
the “near roadway” variable described previously, 28.4% of the PM2.5 concentrations used for 
exposure assignment to cohort participants were influenced by traffic-related factors. The other 
methods of exposure assessment included utilizing the value of the nearest monitor, inverse 
distance weighting, and applying the daily, city-wide PM2.5 average for a year-long exposure 
window. While the study also examined some components of PM2.5, this paper will solely focus 
on the Sun et al.’s results regarding the influence on CAC by total PM2.5, which ranged from 
10.3-16.2 μg/m3. The relative risk for presence of CAC by each of the three previously 
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mentioned exposure estimation methods (Section II, Part A: Study Design, Cohort Selection and 
Exposure Estimation) were not significant in any of the models, with ratios ranging from 0.99 to 
1.02. The investigators also log-transformed positive CAC scores to test for associations with 
PM2.5, but did not find that analysis to be statistically significant [9].  
Kim et al. utilized linear regression to examine possible relevant associations of PM2.5 
concentrations and log-transformed CAC measures, similar to previous studies. The researchers 
also conducted a relative risk assessment for presence of CAC within their cohort. As in the 
Kaufman study, four separate models were considered for regression analysis, which were 
identical to those in the Kaufman et al. study (2012). The mean non-zero Agatston score was 
281.7 (SD = 519.4) in the 48.9% of included participants with measurable CAC. Associations 
were reported for an increase of one interquartile range in each exposure model. The log(CAC) 
associations ranged from 0.956-0.983 for the spatiotemporal model and 0.894-1.020 for the 
national model, with all confidence intervals spanning the null value. Similarly, relative risk for 
presence of CAC ranged 0.997-1.028 for the spatiotemporal model and 1.021-1.106 for the 
national model, again with confidence intervals containing the null value. Based on these results, 
there is very little evidence for an association between CAC and PM2.5 [8]. 
B. The Heinz-Nixdorf Recall Study (HNRS)  
The HNRS is a prospective cohort study that includes 4,814 individuals from three major 
cities in Germany: Essen, Mulheim, and Bochum. These cities are located in the highly 
industrialized and highly populated Ruhr valley. This specific region covers approximately 
600km2 (~232mi2) and has a population 1.2 million [13]. Baseline testing for the participants was 
from 2000-2003. As in the MESA study, data were also collected on factors that may affect 
progression of atherosclerosis, including smoking status, cholesterol, disease status, and 
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hypertension [12, 13]. Interestingly, the HNRS did not collect data on race/ethnicity of the 
participants. 
1. HNRS Methods and Study Design 
 The only relevant study to utilize the Heinz Nixdorf Recall Study was Hoffmann et al. 
(2007), which assessed long-term ambient fine particulate matter exposure and distance to 
roadway with CAC. The sample size for this study was 4,494 after preliminary exclusions for 
address geolocation. Similar to the MESA cohort, the CAC scores were quantified using the 
Agatston score and were conducted at baseline recruitment. Measured concentrations of PM2.5 
were collected daily in 2002, and the average concentration for that year was used for exposure 
estimates as it was the midpoint year of the study recruitment (2002). The European Air 
Pollution Dispersion Model (EURAD) was used to estimate daily values from official emission 
inventories, meteorological information, and regional topographic data. The yearly PM2.5 
concentrations were visualized on 5km grids for the region to illustrate spatial variability. The 
estimated values showed a 0.86-0.88 correlation with actual collected PM2.5 concentrations from 
sampled sites [13]. The residential addresses were geo-located and overlaid with the grid 
estimates, resulting in the ambient PM2.5 concentrations used for exposure assessment. Distance 
to roadway was also used as an exposure contributor of PM2.5 and categorized with respect to 
major roads [13]. Bauer et al. (2010) was able to improve the specificity of the estimates by 
reducing the grid size from 5 to 1km2, but did not specifically examine CAC as an endpoint [12].  
2. HNRS Statistical Analysis and Results 
Hoffman et al. adjusted for age and sex as potential confounders, but did not include race 
/ ethnicity, as the MESA study did. The reason for this omission is possibly due to a 
homogeneous racial makeup of the cohort. Similarly to previous studies, multiple models were 
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derived for the purpose of linear regression to determine associations on those individuals with a 
natural logarithm CAC score greater than one. PM2.5 measurements, originally continuous, were 
then classified into quartiles for interval analysis. Associations were also examined between 
CAC and each classification of road distance: 0-50, 51-100, 101-200, and 200+ meters from 
residential address. Many models were used to separately control for confounding factors. Age 
and sex considered as potential confounders and were accounted for in Model 3. The researchers 
concluded that individuals living less than 50m to a major road have higher CAC scores, as well 
as increased risk of adverse cardiovascular effects [13]. Interestingly, the researchers did find 
that living within 50m of major road is associated with a 10.2% increase in CAC. However, 
Hoffman et al. found that PM2.5 exposure and distance to a major road were not correlated. 
Throughout the five different models examined, each controlling for potential confounders, 
percent increases in CAC with reduced distance to road were 7-10.1%. Odds ratios for scores 
above the age- and sex-specific 75th percentile were elevated but not statistically significant, as 
they included the null effect. The findings from this study suggest an association between PM2.5 
exposure and CAC, but researchers claim the potential for exposure misclassification as simple 
distance measurements did not account for influences from multiple roads [13].  
C. Key Points 
 Table 1 provides a summary of comparable points from each of the previous studies. 
Each study did find a weak positive correlation between ambient PM2.5 and CAC; all confidence 
intervals from each model in each study contained the null value, however, making the results 
not statistically significant [8, 9, 11, 13]. Diez-Roux, Sun, and Kim all tested the relative risk of 
detectable CAC in participants of the top tier of PM2.5 exposure compared to those in the lowest 
tier, each with slightly positive, but not statistically significant results [8, 9, 11]. These separate 
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cohorts examined populations in different parts of the world, but baseline data and subsequent 
outcome assessment were performed at the same time as each study was cross-sectional. Each 
group collected possible confounders in addition to the indices of interest. The age of 
participants also was consistent across both cohorts, as was the methodology of collecting CAC 
measurements. This methodology used the same scanner in the entire HNRS and three (New 
York, Chicago, and Los Angeles) of the MESA cohorts (GE Imatron C-150, San Francisco, 
California) [9, 12, 13]. Though the equipment may not have been the same, the methodologies 
were consistent and considering the total CAC score is reported as opposed to the Agatston 
score, the differences are considered to be negligible. 
 The results from all five studies vary but share some similarities which can be compared. 
The intra-cohort MESA studies drew from the same baseline CAC Agatston scores and method 
of collection, but differed in their separate exposure assessment methods. Fortunately, Hoffmann 
et al. utilized the same equipment and scoring method as the initial MESA baseline testing, 
though the exposure analysis was different. All research groups examined the association of log-
transformed non-zero Agatston scores with continuous PM2.5 exposure estimates. Hoffmann et 
al. found a significant correlation between distance to roadway and CAC, but the findings did 
not correlate significantly with ambient PM2.5 exposure. The results are comparable, even though 
the method of assessing exposure for each of the participants varied, along with the study domain 
between the two cohorts. While not definitive individually, collective insights from the studies’ 
approaches and results can be applied to future research examining the association between 
PM2.5 and CAC.  
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Table 1. Summary of Articles Examining Ambient PM2.5 Exposure and CAC 
Author, 
year, 
cohort 
Sample 
Size 
Exposure 
Assessment 
Examination 
Method 
Associations Comments 
Diez-Roux 
et al. 2007, 
 
MESA 
5,172 20-year average of 
residential PM2.5 
from USEPA 
Aerometric 
Information 
Retrieval System; 
spatio-temporal 
modeling with 
monthly averages; 
corresponding to 
midpoint year of 
CAC collection 
(2001) 
Differences 
between 90th 
and 10th 
percentile of 
exposure; RR 
RR: 1.00-
1.06; 
Not 
statistically 
significant 
No air sampling for 
exposure assessment; 
limited by sensitivity 
of pollutant estimation 
Kaufman 
et al., 2012, 
 
MESA 
6,226 10-year prospective 
study; outdoor 
monitoring, 
integrated 
sampling, 
deterministic 
models, geospatial 
data, indoor 
monitoring 
Linear 
regression of 
exposure with 
CAC 
progression in 
scores >0 
NA Longitudinal study 
with unpublished 
results as of February 
2015 
Sun et al., 
2013, 
 
MESA 
6,256 Exposure estimates  
during collection; 
used 1-year, 2-
week, and city-
wide averaging 
Linear 
regression 
with nonzero 
CAC; RR 
within IQR 
Linear 
regression 
and IQR RR: 
0.99-1.02, not 
statistically 
significant  
Did not exclude 
participants living far 
away from monitors 
Kim et al., 
2014, 
 
MESA 
5,488 Exposure during 
baseline testing; 
compared 2-week 
city-wide averages 
to a national 
exposure model 
RR assessed 
between IQRs 
of each 
exposure 
model 
RR: 0.997-
1.03 for the 2 
week 
average; 
1.02-1.1 for 
national 
average; 
neither 
statistically 
significant 
Did not directly 
monitor the regions for 
exposure estimates 
and used data from 
MESA but did exclude 
individuals 10km 
away from site due to 
inaccurate exposure 
assessment 
Hoffmann 
et al., 2007, 
 
HNRS 
4,494 Mean daily values 
from EURAD for 
the midpoint year 
(2002); also 
considered 
proximity to 
roadway 
Linear 
regression; 
CAC 
prevalence 
with proximity 
to roadway 
No linear 
associations; 
10.2% 
increase in 
CAC for 
those within 
50m of a road 
Did not examine race 
as a confounder. 
Positive association 
between distance to 
road and CAC, but not 
PM2.5 to road. 
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 Considering the strong associations between ambient air pollution and adverse 
cardiovascular health outcomes, and the established subclinical marker of CAC for 
atherosclerosis, relatively few studies have investigated the direct link between exposure to 
ambient fine particulate matter and calcification [5]. The previous studies in this area have 
utilized data from two cohorts, each with unique exposure assessment methods. The large 
majority of research has focused on less reliable subclinical markers as they show a stronger 
association with increases in ambient PM2.5 concentration [5, 7-9, 11-13].   
III: Testing Associations between PM2.5 and CAC within the Heart 
SCORE Cohort 
A. Introduction 
 Ambient air pollution has been associated with adverse cardiovascular health effects, and 
elevated concentrations of PM2.5 have been linked with increases in mortality and morbidity rates 
[2-6]. Previous studies have examined the association between short-term exposures and acute 
health effects such as stroke and MI, but very few have examined the effects of long-term PM2.5 
exposures [5, 8, 9, 11, 13]. Outcomes associated with long-term PM2.5 exposure can be assessed 
via subclinical measures and do not necessarily produce the hard endpoints associated with acute 
events. Previous studies have examined the CIMT as a subclinical measure of atherosclerosis, a 
major factor in cardiovascular disease [5, 6-9, 11-13]. Though this measurement was found to 
positively correlate with ambient PM2.5, other more deterministic subclinical measures are rarely 
examined. CAC is considered to be a better subclinical measure of atherosclerosis than CIMT, 
though very few studies have examined the relationship between PM2.5 and CAC [5].  
 Of the few studies investigating the association between PM2.5 and CAC, three utilized 
the American MESA cohort and the other utilized data from the German HNRS [5, 7-9, 11, 13]. 
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These cross-sectional studies examined different exposure windows and utilized varying 
methods for determining residential exposure for study participants. All studies found a weak, 
positive association between PM2.5 and CAC, though none of the results were significant [8, 9, 
11, 13]. This study hypothesizes that exposure to higher ambient PM2.5 concentrations will result 
in increased inflammation, as well as a higher CAC score within the Heart Strategies 
Concentrating on Risk Evaluation (Heart SCORE) cohort. A pathway will be investigated for 
associations directly between PM2.5 and CAC, as well as associations between PM2.5, various 
biomarkers, and CAC. 
B. Methods 
 The Heart SCORE cohort, originally 2,000 individuals located in southwest 
Pennsylvania, was recruited from 2003-2006. Demographic data and inflammatory marker 
Interlukin-6 (IL-6) were collected at the first clinical visit. Participants also provided their 
residential address at this date. Several exclusions, made based off geocoded address and 
availability of biomarkers are described in 4. Biological Markers2. Geolocating Addresses. CAC 
examination was conducted from 2003-2008 using electron beam tomography, similar to the 
MESA and HNRS cohorts [18, 19]. This group has previously been classified as having less than 
ideal cardiovascular health classified by smoking status, body mass index (BMI), physical 
activity, diet, cholesterol, blood pressure, and glucose level. The Heart SCORE cohort is 
considered high risk group for adverse cardiovascular health events [20]. 
1. Exposure Study Domain 
 The study domain was limited to Allegheny County, Pennsylvania. A spatially saturated 
air monitoring campaign was conducted at the University of Pittsburgh, across an established 
domain capturing major industrial and traffic sources surrounding the Pittsburgh metropolitan 
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area [21, 22]. Researchers collected weeklong integrated samples of PM2.5 throughout the 
domain during summer 2012 and winter 2013. This domain captured 209 of the 1175 km2 within 
Allegheny County (20.5%). Land use regression (LUR) was used, which is based on the 
principle that concentrations of pollutants at any location are dependent on the environmental 
characteristics of the surrounding area, and is often used to predict air pollution exposures of 
research study participants. The final model estimates PM2.5 concentrations based on weekly 
sampling sessions within the previously defined domain that were used in building a merged 
annual LUR model, and then extrapolated to derive an exposure surface for Allegheny County.  
The impact of sources outside of Allegheny County could cause inaccurate exposure estimates, 
since we did not sample across other surrounding counties. Therefore, study domain was not 
extrapolated outside of Allegheny County as predicted concentrations farther away from the 
actual sampling domain may not be accurate.   
2. Geolocating Addresses 
 Participant addresses were first standardized for consistency and then further cleaned 
using the ZP4 address identifier (Semaphore Corporation, 2014). Of the original 2,000 addresses, 
31 were post office (P.O.) addresses and excluded. Of the remaining geo-codable addresses, 98% 
(n = 1,930) were accurately matched with an address locator developed from TeleAtlas in GIS 
ArcInfo (Version 10.1, ESRI, Redlands, CA). To determine exposure estimates (described in 3. 
Population Exposure Estimates), a 300m buffer was constructed around each geolocated address 
point, which considers the average PM2.5 concentration within a 300m radius of a participant’s 
address. Participants residences with buffer regions contained completely within the boundary of 
Allegheny County were included in our study population. After all exclusions, the total sample 
size represents 88.2% of the original cohort (n = 1,766) (Figure 1).  
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Figure 1. PM2.5 Concentrations for 1-year Exposure Window 
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3. Population Exposure Estimates 
 The LUR predictive model provides pollutant concentration estimates on a 100m2 grid of 
Allegheny County. A centroid placed in the center of each grid block represents the average 
predicted concentration of PM2.5 for that 100m2 location. For each participant’s residential 
address, the mean predicted PM2.5 concentration from all centroids contained within the 300m 
buffer previously described represents the estimated PM2.5 exposure for that individual.  
The concentrations estimates from this prediction model is only relative to when the air 
monitoring was conducted, however. To temporally adjust for the exposure window relevant to 
when the cohort was tested, a monitoring station in Lawrenceville was considered. Particulate 
matter concentrations have been collected consistently at this permanent EPA monitoring station 
since 2001, which is maintained and operated by the Allegheny County Health Department. Use 
of this monitor was for temporal variability across years not sampled by Tunno et al. as the site 
was contained within the original sampling domain and is considered representative of the area. 
Using monthly average PM2.5 concentrations for the Lawrenceville site, exposure windows of 1-
year and 2-years prior to when each participant was examined were considered. These exposure 
windows were chosen as PM2.5 concentrations. Average PM2.5 concentrations from these 
exposure windows are relative to when each biological markers were collected. As the 
concentrations from the exposure windows are only relative to the Lawrenceville site, a ratio is 
needed to adjust for spatial differences across the domain. Concentration estimates for each 
participant’s address were divided by the median concentration of PM2.5 across the entire 
domain. The subsequent spatial ratio represents the concentration of PM2.5 within a 300m buffer 
of a person’s residence to the median concentration of PM2.5 of the entire domain. The spatial 
ratios derived from LUR model remain the same across the investigated time period. The spatial 
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ratio was then multiplied by the average concentration for each participant’s exposure window 
calculated from the Lawrenceville site. The resulting concentration represents an individual’s 
estimated PM2.5 exposure 1- or 2-years prior to when each biological marker was collected.  
4. Biological Markers 
The marker interleukin-6 (IL-6) was measured at baseline examination and is indicative 
of general inflammation. Though IL-6 is not specifically indicative of cardiovascular 
inflammation, it was examined as a first step in the attempt to associate PM2.5 to CAC by way of 
increasing atherosclerotic risk. As a biological marker specific to cardiovascular health, the 
augmentation index normalized to 75 beats per minute (AI75) was collected at either baseline or 
a follow-up date. Based on these and other measurements, a Framingham reactive hyperemia 
index (FRHI) was calculated. Both of these indices are indicative of atherosclerotic risk as well 
as presence of CAC [23]. Of the original 1,766 participants included after geolocating 
exclusions, 1,658 (93.9%) were tested for IL-6, 41% (724) were tested for CAC, 72.9% (1,288) 
were measured for AI75, and 71.6% (1,264) were scored on FRHI. Of those individuals tested 
for the presence of CAC, 552 of 724 (76%) had a total Agatston score greater than zero. Of these 
participants initially included in the study, 411 have all three cardiovascular measures in 
common. The final sample size of 381 includes participants with all IL-6, AI75, FRHI, and CAC 
markers. Only non-zero CAC scores were included in the final 381-person sample size. 
Demographic information for the cohort before and after exclusions for location and biomarker 
availability is described in Table 2. 
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Table 2: Demographic differences between Heart SCORE cohorts before and after exclusions 
 Original Heart SCORE Cohort 
Heart SCORE Cohort after 
exclusions 
Age*   
Mean 59.2 61.4 
SD 7.6 7.4 
Range 
 
45-75 45-74 
Race (n, %)   
Black 854 (42.7%) 166 (43.6%) 
White 1,095 (54.8%) 198 (52.0%) 
Other 
 
51 (2.5%) 17 (4.4%) 
Sex (n, %)*   
Male 693 (34.7%) 237 (62.2%) 
Female 1,307 (65.3%) 144 (37.8%) 
*Statistically different between 
total and sample groups 
  
Total 2,000 381 
 
For analysis, the results of the final group of 381 participants will be compared to specific 
larger groups of all individuals who had that measure. Figure 2 shows a flow chart of exclusions. 
While a correlation and association via linear regression will be examined for participants in the 
final sample size, these results will be compared to the specific larger groups of all participants 
who share that measure. 
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 Figure 2. Flowchart of exclusions 
5. Statistical Analysis  
 The mean concentration from monthly averages for PM2.5 concentration for each 
participant’s residential location were examined within either a 1- or 2-year exposure window of 
each biomarker’s collection date. The baseline date used for each participant corresponded with 
the date of examination for AI75, FRHI, or CAC, which were all collected at different times. The 
initial exposure window is relative to each participant’s baseline examination date for which IL-6 
and demographic data (age, sex, and race) were collected. The second exposure window is 
relative to exposures for CAC-related measures. The third and final exposure window applies to 
AI75 and FRHI scores. Linear regression will be used to test for associations between all 
measures Variables will be treated as continuous, with non-zero CAC scores logarithmically 
transformed. Pairwise correlation will also be conducted for participants with common measures. 
Original cohort
(n=2,000)
Non-PO 
Addresses 
(n=1,970)
Geolocated 
Addresses
(n=1,930)
Buffered Addresses 
Completely in Allegheny 
County
(n=1,766) Participants 
tested for IL-6
(n=1,658)
Participants 
tested for AI75
(n=1,288)
Participants with 
FRHI scores
(n=1,264)
Participants 
tested for CAC 
(n=724)
Participants with 
non-zero CAC 
scores (n=552)
Participants with 
all measures
(n=381)
24 
 
All analyses with exposure as a variable will use concentrations relative to when that measure 
was collected. Additionally, non-zero CAC scores in the 90th percentile of exposure will be 
compared via a Risk Ratio to those in the 10th percentile. For comparative purposes, all analysis 
will be performed on all individuals with the common measures, as well as those in the smallest 
sample size who have all measures in common.  
C. Results 
 Initial correlations between one-year and two-year exposure estimates were highly 
positively correlated (r = 0.92). Based on this high correlation, one-year exposure windows were 
considered for the remaining analyses. Exposure estimates for the previous year were made with 
respect to collection of all measurements (Table 3). IL-6 levels ranged from 0.04-12 pg/ml (mean 
= 2.2; SD = 1.7). Additional information on markers is shown in Table 4. Linear regression 
between IL-6 and PM2.5 showed positive association (beta values) of 0.095 (CI: 0.004-0.186) in 
crude models and 0.092 (CI: 0.001-0.183) while controlling for age, sex, and race (p<0.05). IL-6 
and PM2.5 also showed a 0.05 correlation (p < 0.05). Scatter plots of tested associations are show 
in Figure 3. 
Table 3. Associated PM2.5 exposure with collected biomarkers 
 Biomarker 
 
IL-6 CAC AI75 and FRHI 
All 
measures 
Final 
Sample Size 
All 
measures 
Final 
Sample Size 
All 
measures 
Final 
Sample Size 
Participants 
with measure 
 
Associated 
PM2.5 exposure 
(µg/m3) 
1,766 
 
 
 
 
15.73  
0.91  
13.05 – 
20.93 
381 
 
 
 
 
15.79 
0.94 
13.42 – 
20.93 
552 
 
 
 
 
15.73  
0.88  
13.65 – 
21.27 
381 
 
 
 
 
15.74 
0.91 
13.65 – 
21.27 
1,288 
 
 
 
 
15.78 
0.88 
14.07 – 
21.01 
381 
 
 
 
 
15.81 
0.88 
14.07 – 
21.01  
 
Mean 
SD 
Range 
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Figure 3: Scatter plots of tested associations
A) PM2.5 (µg/m3) exposure and log(CAC), B) PM2.5 (µg/m3) and IL-6 (pg/ml), C) PM2.5 (µg/m3) and AI75, D) PM2.5 (µg/m3) and 
Framingham index, E) Framingham index and log(CAC), and F) AI75 and 
log(CAC). 
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Table 4. Biomarker data for all tested participants and those with all markers 
Biomarker 
(All measures / final sample size) 
IL-6 (pg/ml) 
(n = 1,658 / 381) 
CAC (total) 
(n = 552 / 381) 
AI75 
(n = 1,288 / 381) 
FRHI 
(n = 1,264 / 381) 
Mean 2.20 / 2.09 222.1 / 187.8 22.82 / 21.3 0.73 / 0.66 
SD 1.7 / 1.5 458.8 / 269.8 18.6 / 17.1 0.46 / 0.43 
Range 0.04 – 12 / 
0.04 – 9.36 
3 – 6332 /  
3 – 1379 
-41.2 – 111.9 / 
-25.1 – 76.3 
-0.58 – 1.94 / 
-0.54 – 1.91 
Nonzero CAC scores were log-transformed and analyzed via linear regression, 
controlling for age, sex, and race. This analysis showed a positive 0.016 association (beta value) 
equating to a 1.04 increase in CAC score for each increase of 1 µg/m3 of PM2.5. This measures 
had a 95% confidence interval of -0.05-0.08, but was statistically not significant from the p-value 
(p = 0.61) and the confidence interval containing the null effect (Table 5 and  
Table 6: Associations via linear regression and pairwise correlation individuals with all measures 
in common (n=381).).The effects of age, sex, and race, on each correlation and association were 
different and unique. All three variables appeared to have an effect on correlations with 
log(CAC) (p < 0.05) except for IL-6.  Correlations with AI75 were influenced by all three 
variables when comparing the largest possible pairs, but race was not statistically significant in 
the final sample size. A positive correlation between AI75 and FRHI was found in both the 
larger comparison and smallest sample group to be statistically significant.  
Nonzero CAC scores were measured in 552 of the 724 participants. To determine relative 
prevalence of coronary artery calcification, exposure ranges for the 90th and the 10th percentile of 
those tested for CAC were calculated (Table 7). Of those within these percentiles, a positive 
relative risk ratio was calculated (1.04), though is not statistically significant (Table 8).  
27 
Table 5. Associations via linear regression and pairwise correlation for all individuals with each measure 
Biomarker 
Statistically significant measures are in bold 
IL-6 
(n=1,766) 
Log(CAC) 
(n=552) 
AI75 
(n=1,288) 
FRHI 
(n=1,264) 
Association with 
PM2.5 
concentration via 
linear regression 
Beta 0.092 0.016 -0.37 -0.01 
p-value 0.04 0.6 0.5 0.41 
r2 0.006 0.19 0.14 0.05 
CI 0.001-0.183 -0.05-0.08 -1.45 – 0.7 -0.04 – 0.016 
Correlations 
PM2.5  
(p-value) 
0.05 (0.04) 0.008 (0.85)1,2,3 -0.03 (0.34) -0.04 (0.2)2,3 
IL-6 
(p-value) 
Log(CAC) 
(p-value) 
0.007 (0.87) 
AI75 
(p-value) 
-0.04 (0.19)1,2,3 -0.03 (0.53)1,2,3 
FRHI 
(p-value) 
-0.03 (0.2) -0.06 (0.2)1,2,3 0.08 (0.006)1,2,3 
Table 6: Associations via linear regression and pairwise correlation individuals with all measures in common (n=381) 
Biomarker 
Statistically significant measures are in bold 
IL-6 Log(CAC) AI75 FRHI 
Association with 
PM2.5 
concentration 
via linear 
regression 
Beta 0.12 0.011,2 -0.51,2,3 -0.0142,3 
p-value 0.14 0.83 0.59 0.55 
r2 0.012 0.19 0.14 0.03 
CI -0.04 – 0.28 -0.06 – 0.08 -2.32 – 1.33 -0.06 – 0.03 
Correlations 
PM2.5  
(p-value) 
0.008 (0.11) -0.013 (0.8)1,2,3 -0.04 (0.4) -0.04 (0.4) 
IL-6 
(p-value) 
Log(CAC) 
(p-value) 
-0.03 (0.66) 
AI75 
(p-value) 
-0.08 (0.1)1,2 -0.001 (0.98)1,2 
FRHI 
(p-value) 
0.01 (0.89) -0.04 (0.4)1,2,3 0.16 (0.001)1,2 
1Age statistically significant 
2Sex statistically significant 
3Race statistically significant 
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Table 7. Relative difference in average CAC of individuals in the 90th and 10th exposure percentile 
# Individuals Average CAC 
90% exposure (>16.96) 73 226.82 
10% exposure (<14.82) 70 152.27 
Table 8. Prevalence of CAC in individuals in the 90th and 10th exposure percentiles 
CAC present No CAC Totals 
90% exposure (>16.96) 54 19 73 
10% exposure (<14.82) 50 20 70 
Totals 104 39 143 
Relative risk 1.04 
95 % CI 0.847 to 1.266 
Significance (95%) P = 0.733 
Measurements of AI75 were collected from 72.9% (n = 1,288) of the geolocated participants. 
Exposure estimates were calculated for the previous year, with respect to when the AI75 
measurement was calculated and a single outlier was removed using the following equation: μ 
+/- 3*σ2, where μ = mean of the population and σ2 = standard deviation. This equation was used 
to identify outliers from the other markers, though none were found. Linear regression between 
this exposure window and AI75 measures were not statistically significant in either a crude 
model, or one controlling for age, sex, and race.  
Finally, FRHI scores were calculated on 71.6% (n = 1,264) of the participants not 
previously excluded. No index measures were deemed to be outliers, as determined by the 
previous equation. Associations via betas from linear regression, both crude and controlling for 
potential confounders, was not statistically significant (p = 0.59 and p = 0.76), with both 
confidence intervals also including the null value. While sex and race were significant modifiers 
(p = 0.01 and p = 0.02), age was not a statistically significant modifier in the model (p = 0.14). 
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Considering the 90th and 10th percentiles for PM2.5 exposure, differences in AI75 and FRHI are 
summarized in Table 9. No statistically significant difference was found between the groups, 
however.  
Table 9. Relative differences between the 90th and 10th percentiles of exposure for average AI75 and average FRHI 
# Individuals Average AI75 Average FRHI 
90% exposure (>16.96) 131 22.73 0.71 
10% exposure (<14.84) 125 22.98 0.73 
AI75 and FRHI are markers of cardiovascular health, but they may be a better indicator 
of atherosclerosis than the general inflammatory marker IL-6. Linear regression was also 
performed on AI75 values and logarithmically-transformed, non-zero CAC measures, while 
controlling for age, sex, and race. All groups of values had been “trimmed” for outliers and only 
individuals with both measures were included (n = 381). An association via linear regression of -
0.009 was found between AI75 and log-transformed, non-zero CAC score (CI: -0.018 - -0.001), 
and was statistically significant (p = 0.03). Potentially confounding variables of sex and age had 
a significant effect (p < 0.05), but not race. Results for linear regression were similar when 
correlating FRHI and CAC scores. An association of -0.102 (CI: -0.248 – 0.043) was calculated 
but not statistically significant (p = 0.17). As with the other regression model, FRHI had 
significant confounding from age and sex, but not race (p = 0.18).  
D. Discussion 
The initial aim of this study was to examine a possible association between PM2.5 and the 
subclinical outcome, CAC. Though CIMT has been associated with elevated ambient PM2.5 
concentrations [5], CAC is proven to be a better marker of cardiovascular disease [5, 8, 9, 11, 
13].  Additionally, indicators of cardiovascular disease (AI75 and FRHI) were also examined. In 
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theory, higher concentrations of ambient PM2.5 exposure would be indicative of a higher chance 
of CAC. The examined pathways in this study are illustrated in Figure 4. All examined pathways 
were examined as crude models and controlled for the potential confounders of age, sex, and 
race. 
While an association was found between PM2.5 and the general inflammatory marker IL-
6, no statistically significant associations with PM2.5 was found for either of the cardiovascular 
clinical measures. Previous studies, including the MESA cohort [24], have reported positive 
correlations between general inflammation and ambient PM2.5 concentrations. As AI75 
decreases, the log(CAC) scores increase, similar to that reported by Avalos et al. (2007) [25]. 
Attempts to directly associate ambient PM2.5 exposure and nonzero CAC scores proved to not be 
statistically significant. Potential confounders of age and sex were significant in all linear 
regression models and are consistent with the controlling models from previous studies [8, 9, 11, 
13]. Race as a confounding variable did not appear statistically significant in either the 
Figure 4. Possible associations between estimated PM2.5 exposure and various clinical measures.
Heavily weighted arrows indicate a statistically significant association from linear regression (p<0.05). Arrows 
with stars indicate a statistically significant pairwise correlation.  
Estimated PM2.5 
IL-6
CAC 
AI75
FRHI 
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exposureIL-6 model, or the AI75log(CAC) linear regression. This finding is different from 
the previous studies, where race was a significant confounder [8, 9, 11, 13].  
The second method of analysis examined the 10th vs. the 90th percentiles of PM2.5 
exposure within the cohort. This method was used by Diez-Roux et al. and Sun et al. to compare 
presence of CAC in the highest and lowest 10% exposed participants in the study [9, 11]. The 
risk ratio was found to be 1.035, but was not statistically significant. This finding is consistent 
with the 1.02 ratio found by Diez-Roux while controlling for the same confounding factors [11]. 
Sun et al. utilized a different method of analysis, determining percentage increases of CAC with 
an increase in the interquartile range (IQR). Their tests found a negative percentage change in 
CAC with increasing PM2.5 exposure (-0.85 - -1.52%, depending on exposure estimation 
method) [9]. A similar analysis within this current study resulted in a -17.16% change in IQR. 
The sample size used for this statistic is smaller than the MESA cohort utilized by Sun et al., 
(about 1/6th the number of participants) which may be the reason for the large difference. When 
comparing the 10th and 90th percentiles of exposure, analysis showed a 48.96% increase between 
the exposure ranges. Hoffmann et al. performed a similar analysis, but used adjusted odds ratios 
for comparing their top quartile of exposure to the standard age and gender specific CAC score. 
Their findings also showed a slightly positive (1.22), but not statistically significant relationship 
between the higher PM2.5 exposures and increased CAC [13].  
The results of the analysis were consistent with some of the previous studies examining 
ambient PM2.5 concentrations with CAC [8, 9, 11, 13]. While our study utilized a different cohort 
and unique exposure data, the association between the estimated concentration and outcome was 
not statistically significant when analyzed via linear regression. The model used in this analysis 
controlled for the same potential confounders of age, sex, and race. One possible explanation for 
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the results is the relatively smaller sample size as the MESA and HNRS cohorts were much 
larger. Examination of the 10th and 90th percentile of exposure for relative difference in CAC 
showed similar results to previous studies using the same comparison method [9, 11].  
Hoffmann et al. were able to find a statistically significant odds ratio (1.45) when 
comparing the CAC values of those living within 100 meters of a road to the 7th percentile of 
age- and sex- specific cardiovascular measures [13]. According to the US EPA – 45 million 
Americans live less than 100 meters from a highway [25].  The Heart SCORE cohort is primarily 
in an urban environment so this variable may have some effect although previous studies have 
shown traffic to not be the main source of PM2.5 in this region [21]. Examination into the effect 
of proximity to roadway may elucidate other associations with CAC, but were not examined in 
this study. 
 While race was controlled for as a potential confounder in all regression models, it was 
not statistically significant in either of the main linear regressions. Within the MESA study, race 
was determined to be a major factor in determining CAC values, which did not seem to be 
consistent with data from the Heart SCORE cohort [27]. The proportion of races was different 
between the cohorts and a larger sample size or more equal racial ratios might show statistical 
significance for race within the Heart SCORE cohort.  
1. Study Strengths and Weaknesses 
 One of the main strengths of this study is the use of a different cohort than the MESA or 
the HNRS. The Heart SCORE cohort represents a racially diverse population living in a complex 
terrain with current and historic industrial activity [19, 21, 22]. This study is similar to the HNRS 
in that the domain encompasses a historically industrial area [13, 21]. The clinical measures were 
consistent with other studies, making the outcome variables comparable [8, 9, 11, 13, 19]. The 
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exposure assessment used techniques similar to the MESA cohort estimations, utilizing PM2.5 
concentrations from monitors and LUR models to create a layer of predicted pollutant 
concentration across the entire study domain [21, 22]. The one-year exposure window was also 
used, similar to previous studies [13]. This study also relied on a government monitoring site to 
temporally adjust for relative exposure windows. Another strength of this study is the similar 
results found to previous studies with larger sample sizes. Analysis methods consistent with the 
literature were used to directly compare relative differences, percentage changes, relative risk 
ratios, and correlations.  
 One of the drawbacks to the study is the comparatively small sample size used after 
exclusions for geolocation and collection of subclinical measures. Also, the population in the 
Heart SCORE cohort after exclusions was only 34.5% male, which may have skewed some of 
the correlations. The smallest sample size, which included participants will all markers, had this 
ratio reversed, with 62.7% male. Women have a lower prevalence of detectable CAC at every 
comparable age for blacks and whites. Additionally, in individuals with measurable CAC, 
Agatston scores were much higher in men than in women [27]. This study employed exposure 
estimation which may be more accurate that previous studies, but the high proportion of female 
participants may have influenced the weak, not statistically significant association between PM2.5 
and CAC in the larger comparisons. Participants in the study may have been misclassified with 
respect due to exposure if they failed to report a change of address at some point during the study 
as the address with respect to each exposure window was used for pollutant estimates. 
Furthermore, this study is cross-sectional, not reflecting changes in CAC measure with 
the corresponding changes in PM2.5 over an extended time period. The initial onset and 
progression of atherosclerosis may occur over a longer time period than examined in this study. 
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Only two years prior to the data collection were able to be examined, not necessarily reflective of 
an individual’s lifetime exposure. The study domain of Allegheny County has an industrious 
past, with high concentrations of PM2.5 prior to the examined exposure window. A limitation to 
this study is the lack of reliable exposure data from this time period. 
E. Conclusion 
To date, this study is one of the few to examine associations between ambient PM2.5 and 
CAC as opposed to CIMT. A hypothesized pathway was investigated with statistically 
significant associations between pollutant concentration and a general inflammatory marker, as 
well as a cardiovascular indicator and CAC. The association found, however, was very low. 
Pairwise correlations were statistically significant between estimated PM2.5 concentrations and 
IL-6. The cardiovascular indicators were weakly correlated with each other and a slight 
association via linear regression was found between AI75 and CAC. 
The analysis did find suggestive evidence of a link between CAC and ambient PM2.5, but 
the results were statistically not significant. Future research into this association will be 
significant to primary and secondary prevention efforts for cardiovascular disease. Considering 
intrapersonal influences and more overt external factors may elucidate potential confounders to 
strengthen the association between PM2.5 and CAC (i.e. direct monitoring, residential air 
sampling, and family history). If a full pathway between primary exposure, inflammatory 
marker, cardiovascular indicator, and clinical outcome can be established, environmental public 
health efforts can then be targeted to specific areas in an effort to reduce the prevalence or 
severity of disease. 
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